| Targeted drug delivery strategies for precision medicines MT Manzari, Y Shamay, H Kiguchi, N Rosen, M Scaltriti, DA Heller Nature Reviews Materials 6 (4), 351-370, 2021 | 463 | 2021 |
| Triepitopic antibody fusions inhibit cetuximab-resistant BRAF and KRAS mutant tumors via EGFR signal repression JB Spangler, MT Manzari, EK Rosalia, TF Chen, KD Wittrup Journal of molecular biology 422 (4), 532-544, 2012 | 50 | 2012 |
| Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition N Bala Tannan, MT Manzari, L Herviou, M Da Silva Ferreira, C Hagen, ... Blood, The Journal of the American Society of Hematology 137 (15), 2057-2069, 2021 | 22 | 2021 |
| Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models MT Manzari, GR Anderson, KH Lin, RS Soderquist, M Çakir, M Zhang, ... Science advances 5 (9), eaaw9162, 2019 | 13 | 2019 |
| Fibronectin type III domain-based fusion proteins A Chilkoti, M Manzari, M Fevre US Patent 10,385,115, 2019 | 13 | 2019 |
| Targeted therapeutic agents comprising multivalent protein-biopolymer fusions A Chilkoti, M Manzari, M Fevre US Patent App. 16/525,374, 2019 | 11 | 2019 |
| Fragment-based drug nanoaggregation reveals drivers of self-assembly OGDAH Chen Chen, You Wu, Shih-Ting Wang, Naxhije Berisha, Mandana T. Manzari ... Nature Communications 14 (8340), 2023 | 1* | 2023 |
| Dual Inhibition of MCL1 and BCL2 in Lymphoma Using Tumor Targeted Nanoparticles NB Bala, MT Manzari, MDS Ferreira, Z Asgari, C Hagen, V Seshan, ... Blood 134, 305, 2019 | 1 | 2019 |
| Make better, data-backed decisions to hit biotech milestones faster MM Honu, B Knezevic, D Yen Trends in Biotechnology, 2024 | | 2024 |
| Compositions and methods for the treatment of trail-resistant cancer A Chilkoti, K Wood, M Manzari US Patent 11,491,206, 2022 | | 2022 |
| DDEL-15. NANOTHERAPEUTIC TARGETING OF TUMOR ENDOTHELIUM FOR ENHANCING DRUG DELIVERY PAST THE BLOOD-BRAIN BARRIER H Kiguchi, D Tylawsky, J Vaynshteyn, J Gerwin, M Manzari, J Shah, N Li, ... Neuro-Oncology 22 (Suppl 3), iii286, 2020 | | 2020 |
| Non-Invasive Cytokine Detection Via Organic Color Center Patch M Kim, J McCaan, C Chen, MT Manzari, ZA Yaari, R Koder, DA Heller Electrochemical Society Meeting Abstracts prime2020, 3424-3424, 2020 | | 2020 |
| Abstract LB-274: Overcoming colorectal cancer resistance to death receptor agonists: Design and delivery of treatment combinations MT Manzari, X Li, G Anderson, K Wood, A Chilkoti Cancer Research 78 (13_Supplement), LB-274-LB-274, 2018 | | 2018 |
| Integrating Protein Engineering and Genomics for Cancer Therapy MT Manzari Duke University, 2018 | | 2018 |
| Targeted Protein Therapeutics As Powerful Tools for Understanding and Overcoming Drug Resistance in Cancer M Manzari 2017 AIChE Annual Meeting, 2017 | | 2017 |
